Max Masucci
Stock Analyst at Roth MKM
(4.20)
# 1,519
Out of 5,043 analysts
167
Total ratings
45%
Success rate
10.3%
Average return
Main Sectors:
Stocks Rated by Max Masucci
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NAUT Nautilus Biotechnology | Initiated Coverage: Buy | $3.5 | $2.25 | +55.56% | 2 | Sep 29, 2026 | |
| RPID Rapid Micro Biosystems | Initiated Coverage: Buy | $3 | $0.8935 | +235.76% | 2 | Sep 29, 2026 | |
| BDSX Biodesix | Reiterated: Buy | $32 → $41 | $26.02 | +57.57% | 10 | Sep 25, 2026 | |
| CSTL Castle Biosciences | Reiterated: Buy | $40 → $50 | $34.42 | +45.26% | 21 | Sep 22, 2026 | |
| MASS 908 Devices | Reiterated: Buy | $13 → $14 | $12.05 | +16.18% | 4 | Sep 22, 2026 | |
| TKNO Alpha Teknova | Reiterated: Buy | $8 → $10 | $8.84 | +13.12% | 6 | Sep 22, 2026 | |
| XGN Exagen | Reiterated: Buy | $9 → $11 | $8.42 | +30.64% | 6 | Sep 22, 2026 | |
| BRKR Bruker | Reiterated: Hold | $75 → $79 | $58.84 | n/a | 4 | Aug 4, 2023 | |
| RVTY Revvity | Reiterated: Buy | $155 → $151 | $154.18 | n/a | 5 | Aug 2, 2023 | |
| GH Guardant Health | Reiterated: Buy | $70 → $53 | $167.47 | n/a | 18 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $5.43 | n/a | 2 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $99 | $67.33 | n/a | 3 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $15 | $3.28 | n/a | 24 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.00 | n/a | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.49 | n/a | 2 | Sep 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.01 | n/a | 2 | Jun 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $100 | $400.71 | n/a | 22 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $1.53 | n/a | 1 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $39 | $1.41 | n/a | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.16 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $470 → $515 | $278.17 | n/a | 16 | Jul 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 | $0.0007 | n/a | 11 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $0.25 | $0.01 | n/a | 1 | Apr 2, 2020 |
Nautilus Biotechnology
Sep 29, 2026
Initiated Coverage: Buy
Price Target: $3.5
Current: $2.25
Upside: +55.56%
Rapid Micro Biosystems
Sep 29, 2026
Initiated Coverage: Buy
Price Target: $3
Current: $0.8935
Upside: +235.76%
Biodesix
Sep 25, 2026
Reiterated: Buy
Price Target: $32 → $41
Current: $26.02
Upside: +57.57%
Castle Biosciences
Sep 22, 2026
Reiterated: Buy
Price Target: $40 → $50
Current: $34.42
Upside: +45.26%
908 Devices
Sep 22, 2026
Reiterated: Buy
Price Target: $13 → $14
Current: $12.05
Upside: +16.18%
Alpha Teknova
Sep 22, 2026
Reiterated: Buy
Price Target: $8 → $10
Current: $8.84
Upside: +13.12%
Exagen
Sep 22, 2026
Reiterated: Buy
Price Target: $9 → $11
Current: $8.42
Upside: +30.64%
Bruker
Aug 4, 2023
Reiterated: Hold
Price Target: $75 → $79
Current: $58.84
Upside: n/a
Revvity
Aug 2, 2023
Reiterated: Buy
Price Target: $155 → $151
Current: $154.18
Upside: n/a
Guardant Health
Feb 24, 2023
Reiterated: Buy
Price Target: $70 → $53
Current: $167.47
Upside: n/a
Dec 13, 2022
Reiterated: Buy
Price Target: $17
Current: $5.43
Upside: n/a
Nov 15, 2022
Reiterated: Buy
Price Target: $5 → $99
Current: $67.33
Upside: n/a
Nov 9, 2022
Reiterated: Hold
Price Target: $18 → $15
Current: $3.28
Upside: n/a
Nov 3, 2022
Reiterated: Buy
Price Target: n/a
Current: $16.00
Upside: n/a
Sep 8, 2022
Reiterated: Buy
Price Target: n/a
Current: $15.49
Upside: n/a
Jun 23, 2022
Reiterated: Buy
Price Target: n/a
Current: $1.01
Upside: n/a
May 6, 2022
Reiterated: Buy
Price Target: $110 → $100
Current: $400.71
Upside: n/a
Nov 29, 2021
Initiated Coverage: Buy
Price Target: $28
Current: $1.53
Upside: n/a
Nov 5, 2021
Reiterated: Buy
Price Target: $32 → $39
Current: $1.41
Upside: n/a
Oct 14, 2021
Reiterated: Hold
Price Target: n/a
Current: $10.16
Upside: n/a
Jul 14, 2021
Reiterated: Buy
Price Target: $470 → $515
Current: $278.17
Upside: n/a
May 6, 2021
Reiterated: Buy
Price Target: $3.5
Current: $0.0007
Upside: n/a
Apr 2, 2020
Initiated Coverage: Buy
Price Target: $0.25
Current: $0.01
Upside: n/a